Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

H Li, B Yang, J Huang, T Xiang, X Yin, J Wan, F Luo… - Toxicology letters, 2013 - Elsevier
Triple-negative (ER-/PR-/HER2-) breast cancer (TNBC) is a severe clinical problem because
of its relatively poorer prognosis, aggressive behavior and lack of targeted therapies …
被引用次数：147 相关文章

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

H Li, B Yang, J Huang, T Xiang, X Yin… - Toxicology …, 2013 - pubmed.ncbi.nlm.nih.gov
Triple-negative (ER-/PR-/HER2-) breast cancer (TNBC) is a severe clinical problem because
of its relatively poorer prognosis, aggressive behavior and lack of targeted therapies …

[引用][C] Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

H Li, B Yang, J Huang, T Xiang, X Yin, J Wan, F Luo… - Toxicology …, 2013 - cir.nii.ac.jp
Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin
signaling pathway | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

H Li, B Yang, J Huang, T Xiang, X Yin, J Wan, F Luo… - Toxicology Letters, 2013 - infona.pl
Triple-negative (ER-/PR-/HER2-) breast cancer (TNBC) is a severe clinical problem because
of its relatively poorer prognosis, aggressive behavior and lack of targeted therapies …

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway.

H Li, B Yang, J Huang, T Xiang, X Yin, J Wan… - Toxicology …, 2013 - europepmc.org
Triple-negative (ER-/PR-/HER2-) breast cancer (TNBC) is a severe clinical problem because
of its relatively poorer prognosis, aggressive behavior and lack of targeted therapies …